ZAVEDOS

This brand name is authorized in Austria, Australia, Brazil, Cyprus, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Lithuania, Malta, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom, South Africa

Active ingredients

The drug ZAVEDOS contains one active pharmaceutical ingredient (API):

1 Idarubicin UNII 5VV3MDU5IE - IDARUBICIN HYDROCHLORIDE

Idarubicin is a DNA intercalating anthracycline which interacts with the enzyme topoisomerase II and has an inhibitory effect on nucleic acid synthesis. Idarubicin has been shown to have a higher potency with respect to daunorubicin and to be an effective agent against murine leukaemia and lymphomas both by i.v. and oral routes. Read about Idarubicin

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
ZAVEDOS Powder for solution for injection	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC
ZAVEDOS Capsules	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
L01DB06	Idarubicin	L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01D Cytotoxic antibiotics and related substances → L01DB Anthracyclines and related substances
Discover more medicines within L01DB06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 4440Q, 7247K
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 522717090058317, 522717090058417
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 23.789-1-06-11
Country: EE	Ravimiamet	Identifier(s): 1041208, 1041219, 1041220, 1041231, 1656064, 1706701, 1706712, 1706723, 1888128
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 60071, 60072
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 001322, 001372, 169185
Country: FR	Base de données publique des médicaments	Identifier(s): 60692261, 65133315, 65964950, 67551530, 67651178, 67815446, 69164614
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 44547, 44552, 44560, 44563
Country: HK	Department of Health Drug Office	Identifier(s): 34636
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-362248325
Country: IE	Health Products Regulatory Authority	Identifier(s): 88223
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 8197
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1010616, 1010617
Country: MT	Medicines Authority	Identifier(s): AA565/58701
Country: NL	Z-Index G-Standaard	Identifier(s): 13881736
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 52507, 52515, 52523
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 6062, 6066
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100072440, 100072456, 100369564
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W65096001, W65097001
Country: SG	Health Sciences Authority	Identifier(s): 06712P, 06713P, 09971P, 09972P, 09973P, 12455P, 12456P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 10803211H
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699524790225, 8699524790232
Country: ZA	Health Products Regulatory Authority	Identifier(s): 33/26/0211, 33/26/0212, 33/26/0213, Y/26/16, Y/26/17